FDA Commercial Speech Restrictions Could Hold Up In Court, Agency Says
Executive Summary
FDA could still enforce restrictions on commercial speech even in light of the recent Supreme Court decision striking down limits on pharmacy advertising of compounding, FDA Associate Chief Counsel Patricia Kaeding said
You may also be interested in...
Ads For New Drugs Would Require FDA Preclearance Under Rx Safety Bill
Promotional materials for recently-approved drugs would receive special scrutiny by the Center for Postmarket Drug Evaluation & Research proposed in Senate legislation
Ads For New Drugs Would Require FDA Preclearance Under Rx Safety Bill
Promotional materials for recently-approved drugs would receive special scrutiny by the Center for Postmarket Drug Evaluation & Research proposed in Senate legislation
DTC Ads Should Cite Range Of Treatment Options, Blue Cross Assoc. Tells FDA
Direct-to-consumer advertising should include disclosures to note when a particular drug is one of a range of available treatment choices, the Blue Cross and Blue Shield Association said in comments to FDA